Page 425 - ஒன்றுபட்டது மாநிலங்களில் பத்திரங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Business Wire. The AP news staff was not involved in its creation. Genprex Announces Formation of Clinical Advisory Board February 8, 2021 GMT AUSTIN, Texas (BUSINESS WIRE) Feb 8, 2021 Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX ), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced the formation of a Clinical Advisory Board (CAB) to support its oncology and diabetes development programs. Comprised of preeminent clinical specialists, the CAB will lead and advise Genprex as it advances its REQORSA™ immunogene therapy program, including its Acclaim clinical trials in non-small cell lung cancer, and its preclinical diabetes gene therapy program. Some of the members also serve in additional roles at the Company.

United statesSan antonioWest pointMichael morseRodney varnerHarvard brighamKalyn dabbsWilliame gannon jrAstrazeneca tagrissoAndrewb beckerCancer care programContract research organizationAmerican society of clinical oncologyAmerican society for clinical investigationSociety for the immunotherapy of cancerMd anderson cancer center